Notice2022-24470
Oncologic Drugs Advisory Committee; Cancellation
Primary source
Metadata and text below are from the Federal Register, a public-domain U.S. government work. Always verify the official published version before relying on it for any legal matter.
Published
November 9, 2022
Issuing agencies
Health and Human Services DepartmentFood and Drug Administration
Abstract
The meeting of the Oncologic Drugs Advisory Committee scheduled for November 22, 2022, is canceled. This meeting was announced in the Federal Register of September 22, 2022. The meeting is no longer needed.
Full Text
<html>
<head>
<title>Federal Register, Volume 87 Issue 216 (Wednesday, November 9, 2022)</title>
</head>
<body><pre>
[Federal Register Volume 87, Number 216 (Wednesday, November 9, 2022)]
[Notices]
[Page 67696]
From the Federal Register Online via the Government Publishing Office [<a href="http://www.gpo.gov">www.gpo.gov</a>]
[FR Doc No: 2022-24470]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Food and Drug Administration
[Docket No. FDA-2022-N-2174]
Oncologic Drugs Advisory Committee; Cancellation
AGENCY: Food and Drug Administration, HHS.
ACTION: Notice.
-----------------------------------------------------------------------
SUMMARY: The meeting of the Oncologic Drugs Advisory Committee
scheduled for November 22, 2022, is canceled. This meeting was
announced in the Federal Register of September 22, 2022. The meeting is
no longer needed.
FOR FURTHER INFORMATION CONTACT: Joyce Frimpong, Center for Drug
Evaluation and Research, Food and Drug Administration, 10903 New
Hampshire Ave., Bldg. 31, Rm. 2417, Silver Spring, MD 20993-0002, 301-
796-7973, <a href="/cdn-cgi/l/email-protection#2d62696c6e6d4b494c0345455e034a425b"><span class="__cf_email__" data-cfemail="064942474546606267286e6e7528616970">[email protected]</span></a>, or FDA Advisory Committee Information Line,
1-800-741-8138 (301-443-0572 in the Washington, DC area), and follow
the prompts to the desired center or product area. Please call the
Information Line for up-to-date information on this meeting, which was
announced in the Federal Register of September 22, 2022 (87 FR 57904).
Dated: November 3, 2022.
Lauren K. Roth,
Associate Commissioner for Policy.
[FR Doc. 2022-24470 Filed 11-8-22; 8:45 am]
BILLING CODE 4164-01-P
</pre><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script></body>
</html>Indexed from Federal Register on November 9, 2022.
This is legal information, not legal advice. Laws vary by jurisdiction and change frequently. Always verify current law with official sources and consult a licensed attorney in your jurisdiction for advice on your specific situation.